ClassID:

92900

C07C239/20 - CPC Classification

Classification description:

Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof; Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified

Recent Application in this class:
#1
20210387173
2021-12-16

HYDROGENATION PROCESS OF OXIME DERIVATIVES

#2
20210363098
2021-11-25

Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation

#3
20210292275
2021-09-23

Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules

#4
20210139415
2021-05-13

Oligomeric alkoxy amines

#5
20210130301
2021-05-06

Compositions for the treatment of pulmonary fibrosis

#6
20210107928
2021-04-15

SPHINGOSINE-1-PHOSPHATE ANALOG AND SYNTHESIS METHOD THEREFOR

#7
20200024223
2020-01-23

CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME

#8
20190270712
2019-09-05

Compositions for the treatment of pulmonary fibrosis

#9
20190185413
2019-06-20

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

#10
20190040002
2019-02-07

CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME

#11
20180297935
2018-10-18

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#12
20180230080
2018-08-16

Adenylyl cyclase inhibitors for neuropathic and inflammatory pain

#13
20180078517
2018-03-22

β-substituted β-amino acids and analogs as chemotherapeutic agents

#14
20180072682
2018-03-15

Compositions for the treatment of fibrosis and fibrosis-related conditions

#15
20170362166
2017-12-21

β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof

#16
20170246135
2017-08-31

β-substituted γ-amino acids and analogs as chemotherapeutic agents

#17
20170088507
2017-03-30

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#18
20170036992
2017-02-09

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#19
20160289172
2016-10-06

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

#20
20160289168
2016-10-06

β-substituted γ-amino acids and analogs as chemotherapeutic agents

#21
20160272572
2016-09-22

Adenylyl cyclase inhibitors for neuropathic and inflammatory pain

#22
20160185710
2016-06-30

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

#23
20160145273
2016-05-26

PRECATALYST FOR SHIBASAKI'S RARE EARTH METAL BINOLATE CATALYSTS

#24
20160130216
2016-05-12

Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof

#25
20160115130
2016-04-28

Alkoxyamines for the treatment of cancers

#26
20160108001
2016-04-21

Process for the stereoselective preparation of a pyrazole-carboxamide

#27
20150218086
2015-08-06

β-substituted β-amino acids and analogs as chemotherapeutic agents

#28
20150218085
2015-08-06

β-substituted γ-amino acids and analogs as chemotherapeutic agents

#29
20150175652
2015-06-25

Method of purifying/concentrating sugar chains with a sugar chain-trapping molecule and method of analyzing sugar chain structure

#30
20150133407
2015-05-14

Compositions and methods for the treatment of respiratory disorders

#31
20140187558
2014-07-03

Preparation of sitagliptin intermediates

#32
20140031230
2014-01-30

Auxin biosynthesis inhibitor

#33
20130338398
2013-12-19

Process for preparing benzofurans

#34
20130296600
2013-11-07

Process for producing oseltamivir phosphate and intermediate compound

#35
20130244944
2013-09-19

Synthetic ion channels

#36
20130072535
2013-03-21

Pyrazolecarboxamide derivatives and their use as microbiocides

#37
20130012480
2013-01-10

Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same

#38
20120202867
2012-08-09

Microbiocides

#39
20120172407
2012-07-05

N-alkoxycarboxamides and their use as microbiocides

#40
20120122971
2012-05-17

NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS

#41
20110319664
2011-12-29

Method for preparing atomoxetine

#42
20110230537
2011-09-22

Pyrazole-4-N-alkoxycarboxamides as microbiocides

#43
20110224429
2011-09-15

Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound

#44
20110092739
2011-04-21

Lipid Nanoparticle Based Compositions and Methods for the Delivery of Biologically Active Molecules

#45
20110082302
2011-04-07

Process for producing oseltamivir phosphate and intermediate compound

#46
20100292319
2010-11-18

Process for preparing benzofurans

#47
20100197799
2010-08-05

HYDROXYLAMINE DERIVATIVES

#48
20100068139
2010-03-18

Methods of radiofluorination of biologically active vectors

#49
20100063308
2010-03-11

Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules

#50
20100048953
2010-02-25

Process for preparing 2-aminooxyethanol

#51
20090156685
2009-06-18

(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

#52
20090149415
2009-06-11

Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex

#53
20090131707
2009-05-21

CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS

#54
20090118515
2009-05-07

PROCESS FOR PREPARING INTERMEDIATES USEFUL TO PREPARE CERTAIN ANTIBACTERIAL N-FORMYL HYDROXYLAMINES

#55
20090074746
2009-03-19

Compounds to treat alzheimer's disease

#56
20080188675
2008-08-07

Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules

#57
20080146513
2008-06-19

Synthetic ion channels

#58
20080015169
2008-01-17

Amino-methyl substituted tetracycline compounds

#59
20070293547
2007-12-20

Compounds and compositions as LXR modulators

#60
20070281865
2007-12-06

MULTI-FUNCTIONAL SPACER FOR GLYCANS

#61
20070244328
2007-10-18

Organocatalysts and methods of use in chemical synthesis

#62
20070238781
2007-10-11

Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex

#63
20070219274
2007-09-20

(R)-Chiral Halogenated Substituted Fused Heterocyclic Amino Compounds Useful for Inhibiting Cholesterol Ester Transfer Protein Activity

#64
20070191516
2007-08-16

Process for the synthesis of amine ethers

#65
20070179298
2007-08-02

Chemical process for the preparation of intermediates to obtain -formyl hydroxy-lamine compounds

#66
20070179293
2007-08-02

Method for the production of o-substituted hydroxylamine compounds

#67
20070060753
2007-03-15

Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines

#68
20070055081
2007-03-08

Processes for production of alpha-aminooxyketones and alpha-hydroxyketones

#69
20070049643
2007-03-01

Hydroxylamine derivatives

#70
20060293525
2006-12-28

Optically active α-aminooxyketone derivatives and process for production thereof

#71
20060240554
2006-10-26

Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules

#72
20060229304
2006-10-12

(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

#73
20060211860
2006-09-21

Compounds for the treatment of Alzheimer's disease

#74
20060188996
2006-08-24

Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure

#75
20050203096
2005-09-15

Compounds to treat Alzheimer's disease

#76
20050153958
2005-07-14

Substituted aryl ketones

#77
20050113450
2005-05-26

Antibacterial agents

#78
20050096360
2005-05-05

Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment of diseases

#79
20050085645
2005-04-21

O-(3-chloropropenyl) hydroxylamine free base

#80
20050080024
2005-04-14

Nitric oxide donating derivatives for the treatment of cardiovascular disorders

#81
20050065344
2005-03-24

Reagents for N-amination

#82
20050043294
2005-02-24

(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity

#83
20050026875
2005-02-03

Amino-methyl substituted tetracycline compounds